| Rolling Hills Eye Pllc | |
|
1045 N Grand Ave Ste E, Pullman, WA 99163-3473 | |
| (509) 334-3610 | |
| (509) 334-1436 |
| Full Name | Rolling Hills Eye Pllc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1045 N Grand Ave Ste E, Pullman, Washington |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467230979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Darin L Paulson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1437231453 PECOS PAC ID: 2860562857 Enrollment ID: I20100224000422 |
News Archive
A newly completed New York University study of public reaction to the 9/11 attacks concludes that people in positions of power, from government officials to managers working on Wall Street to military personnel, tended to interpret the events in more abstract terms and with more certainty and positivity than ordinary individuals.
The discovery is an important step toward therapies that aim to repair the brain not by introducing new stem cells but rather by spurring those that are already present into action, says the study's lead author Freda Miller of the University of Toronto-affiliated Hospital for Sick Children. The fact that it's a drug that is so widely used and so safe makes the news all that much better.
Waters Corporation (NYSE: WAT) today hosted Dr. Lawrence Zintek, National Organic Methods Development Expert, United States Environmental Protection Agency Region 5 Central Regional Laboratory in Chicago, and author of two new rapid screening methods for Alkylphenols and Bisphenol A (BPA) using Waters® ACQUITY UPLC®/Quattro Premier(TM) XE (UPLC/MS/MS) recently published in American Society for Testing and Materials (ASTM) International. Dr. Zintek was the keynote speaker at a Waters' breakfast seminar held in conjunction with the Water Quality Technology Conference sponsored by the American Water Works Association in Seattle.
Cannabinoids, the active ingredients in marijuana, restrict the sprouting of blood vessels to brain tumors by inhibiting the expression of genes needed for the production of vascular endothelial growth factor (VEGF).
Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.
› Verified 9 days ago
| Provider Name | Suzanne D Scott |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1326120338 PECOS PAC ID: 7315017308 Enrollment ID: I20100302000893 |
News Archive
A newly completed New York University study of public reaction to the 9/11 attacks concludes that people in positions of power, from government officials to managers working on Wall Street to military personnel, tended to interpret the events in more abstract terms and with more certainty and positivity than ordinary individuals.
The discovery is an important step toward therapies that aim to repair the brain not by introducing new stem cells but rather by spurring those that are already present into action, says the study's lead author Freda Miller of the University of Toronto-affiliated Hospital for Sick Children. The fact that it's a drug that is so widely used and so safe makes the news all that much better.
Waters Corporation (NYSE: WAT) today hosted Dr. Lawrence Zintek, National Organic Methods Development Expert, United States Environmental Protection Agency Region 5 Central Regional Laboratory in Chicago, and author of two new rapid screening methods for Alkylphenols and Bisphenol A (BPA) using Waters® ACQUITY UPLC®/Quattro Premier(TM) XE (UPLC/MS/MS) recently published in American Society for Testing and Materials (ASTM) International. Dr. Zintek was the keynote speaker at a Waters' breakfast seminar held in conjunction with the Water Quality Technology Conference sponsored by the American Water Works Association in Seattle.
Cannabinoids, the active ingredients in marijuana, restrict the sprouting of blood vessels to brain tumors by inhibiting the expression of genes needed for the production of vascular endothelial growth factor (VEGF).
Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.
› Verified 9 days ago
| Provider Name | Matthew G Walker |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1598286635 PECOS PAC ID: 7810253283 Enrollment ID: I20171117002540 |
News Archive
A newly completed New York University study of public reaction to the 9/11 attacks concludes that people in positions of power, from government officials to managers working on Wall Street to military personnel, tended to interpret the events in more abstract terms and with more certainty and positivity than ordinary individuals.
The discovery is an important step toward therapies that aim to repair the brain not by introducing new stem cells but rather by spurring those that are already present into action, says the study's lead author Freda Miller of the University of Toronto-affiliated Hospital for Sick Children. The fact that it's a drug that is so widely used and so safe makes the news all that much better.
Waters Corporation (NYSE: WAT) today hosted Dr. Lawrence Zintek, National Organic Methods Development Expert, United States Environmental Protection Agency Region 5 Central Regional Laboratory in Chicago, and author of two new rapid screening methods for Alkylphenols and Bisphenol A (BPA) using Waters® ACQUITY UPLC®/Quattro Premier(TM) XE (UPLC/MS/MS) recently published in American Society for Testing and Materials (ASTM) International. Dr. Zintek was the keynote speaker at a Waters' breakfast seminar held in conjunction with the Water Quality Technology Conference sponsored by the American Water Works Association in Seattle.
Cannabinoids, the active ingredients in marijuana, restrict the sprouting of blood vessels to brain tumors by inhibiting the expression of genes needed for the production of vascular endothelial growth factor (VEGF).
Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rolling Hills Eye Pllc 1045 N Grand Ave Ste E, Pullman, WA 99163-3473 Ph: (509) 334-3610 | Rolling Hills Eye Pllc 1045 N Grand Ave Ste E, Pullman, WA 99163-3473 Ph: (509) 334-3610 |
News Archive
A newly completed New York University study of public reaction to the 9/11 attacks concludes that people in positions of power, from government officials to managers working on Wall Street to military personnel, tended to interpret the events in more abstract terms and with more certainty and positivity than ordinary individuals.
The discovery is an important step toward therapies that aim to repair the brain not by introducing new stem cells but rather by spurring those that are already present into action, says the study's lead author Freda Miller of the University of Toronto-affiliated Hospital for Sick Children. The fact that it's a drug that is so widely used and so safe makes the news all that much better.
Waters Corporation (NYSE: WAT) today hosted Dr. Lawrence Zintek, National Organic Methods Development Expert, United States Environmental Protection Agency Region 5 Central Regional Laboratory in Chicago, and author of two new rapid screening methods for Alkylphenols and Bisphenol A (BPA) using Waters® ACQUITY UPLC®/Quattro Premier(TM) XE (UPLC/MS/MS) recently published in American Society for Testing and Materials (ASTM) International. Dr. Zintek was the keynote speaker at a Waters' breakfast seminar held in conjunction with the Water Quality Technology Conference sponsored by the American Water Works Association in Seattle.
Cannabinoids, the active ingredients in marijuana, restrict the sprouting of blood vessels to brain tumors by inhibiting the expression of genes needed for the production of vascular endothelial growth factor (VEGF).
Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.
› Verified 9 days ago
Eye And Wellness, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1690 Se Harvest Dr, Pullman, WA 99163 Phone: 509-334-2990 | |
Family Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 560 Se Bishop Blvd, Pullman, WA 99163 Phone: 509-334-3300 Fax: 509-334-7591 | |
Dr. James P Devleming, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 238 E Main St, Pullman, WA 99163 Phone: 509-334-1131 Fax: 509-332-4062 | |
Dr. Rachna Narula, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1125 Se Washington St, Pullman, WA 99164 Phone: 509-335-0360 | |
Dr. Suzanne Denise Scott, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1045 N Grand Ave, Suite E, Pullman, WA 99163 Phone: 509-334-3610 Fax: 509-334-1462 | |
Dr. Darin Lee Paulson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1045 N Grand Ave, Suite E, Pullman, WA 99163 Phone: 509-334-3610 Fax: 509-334-1462 |